Skip to main content
Geratherm Medical AG logo

Geratherm Medical AG — Investor Relations & Filings

Ticker · GME ISIN · DE0005495626 LEI · 391200RRY20H0XD6QC53 F Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 485 across all filing types
Latest filing 2026-06-08 Report Publication Anno…
Country DE Germany
Listing F GME

About Geratherm Medical AG

https://geratherm.com/

Geratherm Medical AG is a medical technology company that develops and produces a range of medical devices and solutions for both professional and home use. For the professional market, the company provides systems for pulmonary function diagnostics, including spirometry, pulmonary function tests (PFT), and cardiopulmonary stress tests (CPET). It also offers specialized equipment such as the nomag®IC advanced, an MR diagnostics incubator system for newborns. For the consumer and home care market, Geratherm offers a portfolio of healthcare diagnostic products designed to monitor vital data. This includes clinical thermometers, blood pressure monitors, and products for women's health, such as pregnancy tests and tools for natural family planning.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2026
Report Publication Announcement Classification · 90% confidence The document is a brief EQS news release announcing the preliminary publication date and link for the group’s annual financial report. It contains no actual financial data or statements—only a notice that the Annual Report will be disclosed on June 11, 2026. Under the “Menu vs. Meal” rule, this is a report publication announcement, not the report itself.
2026-06-08 English
Hinweis auf Konzernabschluss vom 01.01.2025 bis zum 31.12.2025
Report Publication Announcement Classification · 95% confidence The text is a brief notice indicating that the group financial statements (covering 01.01.2025–31.12.2025) have been published and are available online. It does not contain any actual financial data, only a link and publication details. Under the “Menu vs Meal” rule, this is an announcement of report availability rather than the report itself, so it should be classified as a Report Publication Announcement (RPA).
2026-06-08 German
Konzernabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Annual Report Classification · 100% confidence The document is a comprehensive 'Konzernabschluss' (Consolidated Financial Statement) for MRH Trowe Holding GmbH for the fiscal year 2024. It includes a balance sheet (Konzernbilanz), profit and loss statement (Gewinn- und Verlustrechnung), cash flow statement (Kapitalflussrechnung), statement of changes in equity (Konzerneigenkapitalspiegel), and notes (Konzernanhang). As this is a full annual financial report containing audited financial statements for the full fiscal year, it is classified as an Annual Report (10-K). FY 2024
2026-03-30 German
Geratherm Medical AG wechselt Borsensegment und wird kunftig im Segment Open Market - Basic Board statt SCALE der Frankfurter Wertpapierborse gehandelt.
Regulatory Filings Classification · 95% confidence The document is a corporate news announcement from Geratherm Medical AG regarding a change in its stock exchange segment (moving from the 'SCALE' segment to the 'Basic Board' of the Frankfurt Stock Exchange). While this involves a change in listing status, it is not a formal delisting from the exchange itself, but rather a segment migration. Given the nature of the announcement as a corporate news release regarding market segment status, it fits best under 'Regulatory Filings' (RNS) as it is a general regulatory/corporate announcement that does not fall into the specific categories of delisting (DLST) or share capital changes (SHA).
2026-01-29 German
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
Interim / Quarterly Report Classification · 95% confidence The document is a comprehensive 'Konzernabschluss' (Consolidated Financial Statement) for MRH Trowe Holding GmbH for the fiscal year 2023. It includes a consolidated balance sheet (Konzernbilanz), income statement (Gewinn- und Verlustrechnung), cash flow statement (Kapitalflussrechnung), statement of changes in equity (Eigenkapitalspiegel), and notes (Konzernanhang). This constitutes a full annual financial report for a period shorter than a full fiscal year in terms of reporting history (first-time consolidated report), but it functions as the primary annual financial disclosure. Given the definitions, this fits the 'Interim / Quarterly Report' (IR) category as it contains substantive financial statements and analysis for a specific period, or more accurately, it is the annual financial report. Since '10-K' is reserved for US-style annual reports and 'IR' covers comprehensive financial reports for periods, 'IR' is the most appropriate classification for this German consolidated financial statement. FY 2023
2025-10-20 German
Report Publication Announcement 2025
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1883 characters) from Geratherm Medical AG stating that a financial report (half-year/Q2) will be disclosed on a future date (August 28, 2025). It provides a link to where the report will be available. Per the 'Menu vs Meal' rule, this is an announcement of a report publication, not the report itself, and therefore falls under the Report Publication Announcement (RPA) category.
2025-08-26 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.